Print

Degussa Biotech Spin-Out Elbion AG Nets 25 Milllon Euros 
10/19/2005 5:12:04 PM

LONDON, Jan 10 (Reuters) - Elbion AG, a privately owned biotechnology firm spun off by German chemicals group Degussa AG (DGXG.DE: Quote, Profile, Research) , has raised 25 million euros ($33 million) in a first round of venture capital funding, it said on Monday.
//-->